Pharmafile Logo
Pharmafocus logo
Advanced Search
az_palmer

Three appointments in AstraZeneca’s global media relations team

January 11, 2016
Medical Communications AstraZeneca

Neil Burrows has joined as head of global media relations, following Esra Erkal-Paler’s promotion to head of global external communications.Burrows …

Appointment

Shire and Baxalta reach $32 billion merger agreement

January 11, 2016
Manufacturing and Production, Sales and Marketing Baxalta, Shire, mergers, mergers and acquisitions

One of the industry’s longest-running M&A sagas has finally reached a conclusion, with Shire and Baxalta announcing a $32 billion …

News

AbbVie begins late stage trials of rheumatoid arthritis drug

January 11, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ABT-494, AbbVie, F-star, JAK-1 inhibitor, rheumatoid arthritis

AbbVie has begun a large phase III clinical trial programme for its next-generation rheumatoid arthritis (RA) treatment ABT-494, which the …

News
Elias Zerhouni

Sanofi seals double oncology research deals

January 11, 2016
Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research

Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …

News
novartis_window

Novartis expands immuno-oncology programme

January 11, 2016
Research and Development, Sales and Marketing Cancer, Novartis, Surface Oncology, collaboration, immuno-oncology

Novartis has further bolstered its immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology, as it moves …

News
GSK logo

GSK explains decision to halt payments to doctors

January 8, 2016
Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …

News
Mylan building

Mylan announces Momenta collaboration to develop six biosimilars

January 8, 2016
Manufacturing and Production, Sales and Marketing Heather Bresch, Momenta, Mylan, biosimilars

Mylan has entered an exclusive global collaboration agreement with Momenta Pharmaceuticals, to develop, manufacture and commercialise six of Momenta’s biosimilar …

News
UK flag

Teva launches biosimilar fertility treatment in the UK

January 8, 2016
Manufacturing and Production, Sales and Marketing Ovaleap, Teva, biosimilar

Teva has launched its biosimilar version of Merck’s fertility treatment Gonal-f in the UK, potentially bringing a more affordable version …

News

PCI Pharma Services expands customer support portal

January 8, 2016
Business Services PCI Pharma Services

PCI Pharma Services has announced the expansion of its proprietary client services online portal, Webflow, into all PCI Clinical Services …

News
Press release
Neil Woodford

Investment group renews calls for GSK to split

January 8, 2016
Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …

News
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016
Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …

Feature
FDA sign

FDA review for Sanofi and Regeneron’s biologic arthritis drug

January 8, 2016
Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab

The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …

News
Roche building

Roche presents new data for advanced bladder cancer immunotherapy

January 8, 2016
Medical Communications, Research and Development Roche, atezolizumab, bladder cancer

Roche has announced updated results from a pivotal Phase II study, showing its investigational cancer immunotherapy atezolizumab extended median progression …

News
Novartis image

Novartis and Qualcomm to develop smart inhaler technology for COPD

January 8, 2016
Manufacturing and Production, Medical Communications COPD, Novartis, Qualcomm Life, breezhaler, digital inhaler, qualcomm

Novartis has enlisted Qualcomm life to help the pharma giant develop the ‘next generation’ of its Breezhaler device for patients …

News
victoria_photo_feb_14

New head for AI drug discovery firm Molplex

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Molplex, Victoria Camargo

The artificial intelligence drug discovery company Molplex has appointed Victoria Camargo as its new chief executive. Camargo replaces the co-founder …

Appointment
HIV infected cell

ViiV and Janssen to test new HIV regimen in Phase III trial

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development Edurant, HIV, Janssen, ViiV Healthcare, cabotegravir, collaboration, phase III, rilpivirine

Janssen has formalised its collaboration with ViiV Healthcare on the Phase III development and commercialisation of a two-drug regimen to …

News
dr_paolo_paoletti

PsiOxus Therapeutics appoints Dr Paolo Paoletti as chairman of the board

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development Cancer, Dr Paolo Paoletti, GSK, PsiOxus Therapeutics, immuno-oncology, oncology

Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …

Appointment
Merck image

Merck and Biocartis partner on new biomarker test for colorectal cancer

January 7, 2016
Research and Development BRAF mutations, Diagnostics, Erbitux, Merck, RAS metations, diagnostic tests, metastic colorectal cancer

Merck has signed a collaboration agreement with diagnostics company Biocartis for the development and commercialisation of a new test for …

News
Janssen image

Janssen, Enterome and Kymab in research collaborations

January 7, 2016
Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research

Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …

News
ian_green

Terrence Higgins Trust announces new CEO

January 6, 2016
Medical Communications AIDS, HIV, Terrance Higgins Trust

Leading UK-based HIV and sexual health charity The Terrence Higgins Trust has announced the appointment of Ian Green as the …

Appointment
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026